Metraipolis › archive › dc_bfce3e89b8b6

Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: Initial In Vivo Proof-of-Concept — Europe PMC PMID:41463784

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41463784
DOI
10.3390/antibiotics14121283
License (as archived)
solo-consultazione
Archived
2026-11-07T13:48:24.481Z
SHA-256 of the archived text
69c2cdbb4596a5b64fd4550254bee9da4d33801aa47f687bf8eb0c15f7ca61f1
Stable URL of this page
https://metraipolis.com/documento/dc_bfce3e89b8b6

How to cite

Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: Initial In Vivo Proof-of-Concept — Europe PMC PMID:41463784 — Europe PMC (en), https://europepmc.org/article/MED/41463784 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfce3e89b8b6 (Metraipolis archive dc_bfce3e89b8b6, sha256 69c2cdbb4596a5b64fd4550254bee9da4d33801aa47f687bf8eb0c15f7ca61f1)
BibTeX
@misc{dcbfce3e89b8b6,
  title = {Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: Initial In Vivo Proof-of-Concept — Europe PMC PMID:41463784},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41463784},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfce3e89b8b6; sha256 69c2cdbb4596a5b64fd4550254bee9da4d33801aa47f687bf8eb0c15f7ca61f1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41463784. Agents can read the archived copy with the MCP tool read_document.